Toxicity Assay Products and Services
|
|
Preclinical toxicity assessment is a critical function in pharmaceutical development that continues to increase in importance. Toxicity is one of the leading causes of drug failures. Utilization of new and improved in vitro technologies and in vivo biomarker assays can lower attrition and increase efficiencies in drug development.
BD Biosciences offers a comprehensive line of antibody-based assay reagents and kits that utilize flow cytometry, fluorescence microscopy, or EIA methods that allow early and accurate assessment of preclinical drug toxicity. Kits for the assessment of genotoxicity are also available.
|
Predictive
In vitro assays that correlate with in vivo toxicity and in vivo biomarker assays linked to histological data.
Comprehensive Portfolio
A full complement of assay solutions to measure renal and hepatic toxicity biomarkers, micronucleus formation, immunotoxicity, apoptosis, cell proliferation, and instrumentation to measure cell-based toxicity.
Labor-saving Kits
Convenient kits containing a full complement of assay reagents, protocols, and controls.
|
Hepatic and Renal Toxicity Biomarker Assays
Genotoxicity Assays
Contract Research Services
|
